Acron Determined to Continue Bid for Polish Rival

Russia's Acron said on Thursday it was determined to go ahead with its 1.5 billion zloty ($438 million) bid for Poland's top chemicals group Azoty Tarnow despite the Polish government's unwillingness to sell its 32% stake.

The Treasury Ministry, which oversees state assets, said on Wednesday that selling its controlling holding would endanger the company's strategy and limit the value of other Polish chemical makers.

"The view expressed by the Polish treasury is more and more surprising to us, as it shows a lack of consistency on the part of the ministry," Acron's deputy head Vladimir Kantor said in a statement. "Acron's bid is an answer to (Poland's) privatization plan for 2012-2013."

Poland is seeking to raise 15 billion zlotys from privatization before the end of 2013, but the sale of state assets to Russian companies is a sensitive issue given the historical tensions between the two countries.

Highlighting the often testy relationship, Polish and Russian soccer supporters clashed on Tuesday when the two neighbours played each other in the Euro 2012 tournament in Warsaw.

Earlier this month, sources told Reuters that the ministry was seeking another bidder to avoid selling its top chemicals group to a Russian rival.

Shares in Tarnow have traded above the 36 zlotys per share offered by Acron, implying investors expect the bid to be sweetened or a "white knight" with an alternative offer.

"We continue our bid for Azoty Tarnow shares," Kantor said. "We believe that as the strategic investor we can ensure long-term benefits both for the group's Polish units as well as all of its shareholders."

 

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.